ESPR Financial Statements

Balance sheet, income statement, cash flow, and dividends for Esperion Therapeutics Inc (ESPR).


$433.48M Market Cap.

As of 03/07/2025 5:00 PM ET (MRY) • Disclaimer

ESPR Market Cap. (MRY)


ESPR Shares Outstanding (MRY)


ESPR Assets (MRY)


Total Assets

$343.82M

Total Liabilities

$732.54M

Total Investments

$0

ESPR Income (MRY)


Revenue

$332.31M

Net Income

-$51.74M

Operating Expense

$209.31M

ESPR Cash Flow (MRY)


CF Operations

-$23.65M

CF Investing

-$317.00K

CF Financing

$86.48M

ESPR Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

ESPR Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$343,821,000 (67.07%)

$205,796,000 (-17.00%)

$247,939,000 (-35.02%)

$381,590,000 (8.02%)

Assets Current

$337,998,000 (68.10%)

$201,065,000 (-18.49%)

$246,683,000 (-25.01%)

$328,972,000 (-4.89%)

Assets Non-Current

$5,823,000 (23.08%)

$4,731,000 (276.67%)

$1,256,000 (-97.61%)

$52,618,000 (614.72%)

Goodwill & Intangible Assets

$56,000 (0.00%)

$56,000 (0.00%)

$56,000 (0.00%)

$56,000 (0.00%)

Shareholders Equity

-$388,722,000 (14.57%)

-$454,994,000 (-40.53%)

-$323,778,000 (-64.40%)

-$196,944,000 (-104.86%)

Property Plant & Equipment Net

$5,767,000 (23.36%)

$4,675,000 (289.58%)

$1,200,000 (-53.16%)

$2,562,000 (-64.93%)

Cash & Equivalents

$144,761,000 (76.01%)

$82,248,000 (-34.08%)

$124,775,000 (-51.80%)

$258,892,000 (-15.11%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

-$2,000 (93.55%)

-$31,000 (0%)

Deferred Revenue

$8,518,000 (-66.47%)

$25,402,000 (624.32%)

$3,507,000 (-44.48%)

$6,317,000 (280.08%)

Total Investments

$0 (0%)

$0 (0%)

$42,086,000 (-16.56%)

$50,441,000 (0%)

Investments Current

$0 (0%)

$0 (0%)

$42,086,000 (-16.56%)

$50,441,000 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$94,491,000 (43.99%)

$65,623,000 (86.42%)

$35,201,000 (2.35%)

$34,394,000 (113.15%)

Trade & Non-Trade Receivables

$80,142,000 (65.26%)

$48,494,000 (43.78%)

$33,729,000 (47.07%)

$22,934,000 (85.13%)

Trade & Non-Trade Payables

$51,650,000 (62.84%)

$31,718,000 (37.66%)

$23,040,000 (31.21%)

$17,559,000 (-66.22%)

Accumulated Retained Earnings (Deficit)

-$1,601,029,000 (-3.34%)

-$1,549,284,000 (-15.62%)

-$1,340,036,000 (-21.12%)

-$1,106,377,000 (-31.90%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$591,212,000 (9.29%)

$540,947,000 (7.21%)

$504,553,000 (-2.45%)

$517,235,000 (42.88%)

Debt Current

$104,902,000 (188.34%)

$36,381,000 (44.69%)

$25,144,000 (98.19%)

$12,687,000 (59.00%)

Debt Non-Current

$486,310,000 (-3.62%)

$504,566,000 (5.25%)

$479,409,000 (-4.98%)

$504,548,000 (42.51%)

Total Liabilities

$732,543,000 (10.86%)

$660,790,000 (15.58%)

$571,717,000 (-1.18%)

$578,534,000 (28.74%)

Liabilities Current

$246,233,000 (57.62%)

$156,224,000 (69.24%)

$92,308,000 (25.84%)

$73,352,000 (-22.02%)

Liabilities Non-Current

$486,310,000 (-3.62%)

$504,566,000 (5.25%)

$479,409,000 (-5.10%)

$505,182,000 (42.18%)

ESPR Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$332,314,000 (185.66%)

$116,334,000 (54.14%)

$75,475,000 (-3.79%)

$78,447,000 (-65.52%)

Cost of Revenue

$68,601,000 (58.55%)

$43,267,000 (60.44%)

$26,967,000 (89.68%)

$14,217,000 (494.36%)

Selling General & Administrative Expense

$163,073,000 (14.42%)

$142,523,000 (30.66%)

$109,082,000 (-41.03%)

$184,985,000 (-7.33%)

Research & Development Expense

$46,238,000 (-46.30%)

$86,107,000 (-27.60%)

$118,927,000 (12.22%)

$105,975,000 (-27.88%)

Operating Expenses

$209,311,000 (-8.45%)

$228,630,000 (0.27%)

$228,009,000 (-21.64%)

$290,960,000 (-16.04%)

Interest Expense

$59,251,000 (0.47%)

$58,976,000 (3.81%)

$56,810,000 (22.56%)

$46,353,000 (104.47%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$51,745,000 (75.27%)

-$209,248,000 (10.45%)

-$233,659,000 (13.17%)

-$269,108,000 (-87.47%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$51,745,000 (75.27%)

-$209,248,000 (10.45%)

-$233,659,000 (13.17%)

-$269,108,000 (-87.47%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$51,745,000 (75.27%)

-$209,248,000 (10.45%)

-$233,659,000 (13.17%)

-$269,108,000 (-87.47%)

Weighted Average Shares

$187,181,856 (81.54%)

$103,106,616 (55.26%)

$66,407,242 (129.76%)

$28,902,507 (5.20%)

Weighted Average Shares Diluted

$187,181,856 (81.54%)

$103,106,616 (55.26%)

$66,407,242 (129.76%)

$28,902,507 (5.20%)

Earning Before Interest & Taxes (EBIT)

$7,506,000 (104.99%)

-$150,272,000 (15.03%)

-$176,849,000 (20.61%)

-$222,755,000 (-84.28%)

Gross Profit

$263,713,000 (260.92%)

$73,067,000 (50.63%)

$48,508,000 (-24.48%)

$64,230,000 (-71.47%)

Operating Income

$54,402,000 (134.97%)

-$155,563,000 (13.34%)

-$179,501,000 (20.83%)

-$226,730,000 (-86.77%)

ESPR Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$317,000 (-100.75%)

$42,500,000 (424.43%)

$8,104,000 (116.05%)

-$50,484,000 (-336.39%)

Net Cash Flow from Financing

$86,484,000 (71.39%)

$50,460,000 (54.76%)

$32,606,000 (-87.84%)

$268,223,000 (32.96%)

Net Cash Flow from Operations

-$23,654,000 (82.54%)

-$135,487,000 (22.50%)

-$174,827,000 (33.73%)

-$263,809,000 (-209.72%)

Net Cash Flow / Change in Cash & Cash Equivalents

$62,513,000 (247.00%)

-$42,527,000 (68.29%)

-$134,117,000 (-191.12%)

-$46,070,000 (-133.41%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$42,500,000 (424.43%)

$8,104,000 (116.05%)

-$50,484,000 (-245.38%)

Capital Expenditure

-$317,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

-$9,912,000 (36.08%)

-$15,506,000 (73.28%)

-$58,024,000 (-225.90%)

$46,088,000 (-81.57%)

Issuance (Purchase) of Equity Shares

$105,993,000 (60.73%)

$65,945,000 (-27.41%)

$90,849,000 (-59.16%)

$222,450,000 (559.93%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$11,993,000 (0.29%)

$11,958,000 (-21.41%)

$15,215,000 (-37.40%)

$24,306,000 (-14.37%)

Depreciation Amortization & Accretion

$63,000 (-61.59%)

$164,000 (-67.20%)

$500,000 (-18.30%)

$612,000 (11.88%)

ESPR Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

79.40% (26.43%)

62.80% (-2.33%)

64.30% (-21.49%)

81.90% (-17.19%)

Profit Margin

-15.60% (91.33%)

-179.90% (41.89%)

-309.60% (9.74%)

-343.00% (-443.58%)

EBITDA Margin

2.30% (101.78%)

-129.00% (44.80%)

-233.70% (17.48%)

-283.20% (-435.35%)

Return on Average Equity (ROAE)

14.80% (-72.28%)

53.40% (-33.83%)

80.70% (-15.05%)

95.00% (-91.41%)

Return on Average Assets (ROAA)

-15.00% (83.62%)

-91.60% (-18.35%)

-77.40% (16.14%)

-92.30% (-79.22%)

Return on Sales (ROS)

2.30% (101.78%)

-129.20% (44.86%)

-234.30% (17.50%)

-284.00% (-434.84%)

Return on Invested Capital (ROIC)

1.40% (104.76%)

-29.40% (5.47%)

-31.10% (30.27%)

-44.60% (35.73%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-7.86 (-433.40%)

-1.47 (16.78%)

-1.77 (-229.61%)

-0.54 (89.20%)

Price to Sales Ratio (P/S)

1.24 (-53.25%)

2.65 (-51.66%)

5.48 (197.61%)

1.84 (-41.32%)

Price to Book Ratio (P/B)

-1.11 (-49.26%)

-0.75 (47.32%)

-1.42 (-92.14%)

-0.74 (90.21%)

Debt to Equity Ratio (D/E)

-1.88 (-29.75%)

-1.45 (17.78%)

-1.77 (39.89%)

-2.94 (37.16%)

Earnings Per Share (EPS)

-0.28 (86.21%)

-2.03 (42.33%)

-3.52 (62.19%)

-9.31 (-78.01%)

Sales Per Share (SPS)

1.77 (57.36%)

1.13 (-0.79%)

1.14 (-58.11%)

2.71 (-67.23%)

Free Cash Flow Per Share (FCFPS)

-0.13 (90.26%)

-1.31 (50.09%)

-2.63 (71.15%)

-9.13 (-191.44%)

Book Value Per Share (BVPS)

-2.08 (52.93%)

-4.41 (9.50%)

-4.88 (28.44%)

-6.81 (-94.74%)

Tangible Assets Book Value Per Share (TABVPS)

1.84 (-7.92%)

2 (-46.56%)

3.73 (-71.72%)

13.2 (2.68%)

Enterprise Value Over EBIT (EV/EBIT)

113 (2360.00%)

-5 (-25.00%)

-4 (-100.00%)

-2 (66.67%)

Enterprise Value Over EBITDA (EV/EBITDA)

112.08 (2323.41%)

-5.04 (-11.87%)

-4.51 (-94.14%)

-2.32 (59.34%)

Asset Turnover

0.96 (88.80%)

0.51 (103.60%)

0.25 (-7.06%)

0.27 (-67.07%)

Current Ratio

1.37 (6.68%)

1.29 (-51.83%)

2.67 (-40.42%)

4.49 (21.97%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$23,971,000 (82.31%)

-$135,487,000 (22.50%)

-$174,827,000 (33.73%)

-$263,809,000 (-206.59%)

Enterprise Value (EV)

$848,345,376 (12.11%)

$756,715,177 (-4.76%)

$794,560,654 (54.13%)

$515,505,785 (-24.96%)

Earnings Before Tax (EBT)

-$51,745,000 (75.27%)

-$209,248,000 (10.45%)

-$233,659,000 (13.17%)

-$269,108,000 (-87.47%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$7,569,000 (105.04%)

-$150,108,000 (14.88%)

-$176,349,000 (20.61%)

-$222,143,000 (-84.61%)

Invested Capital

$543,983,000 (7.04%)

$508,215,000 (-5.07%)

$535,353,000 (-5.50%)

$566,525,000 (79.18%)

Working Capital

$91,765,000 (104.65%)

$44,841,000 (-70.95%)

$154,375,000 (-39.61%)

$255,620,000 (1.51%)

Tangible Asset Value

$343,765,000 (67.09%)

$205,740,000 (-17.00%)

$247,883,000 (-35.03%)

$381,534,000 (8.02%)

Market Capitalization

$433,477,376 (27.49%)

$340,016,177 (-25.93%)

$459,048,654 (215.74%)

$145,386,785 (-79.94%)

Average Equity

-$349,362,250 (10.80%)

-$391,659,750 (-35.22%)

-$289,654,000 (-2.23%)

-$283,338,250 (-2082.42%)

Average Assets

$345,828,500 (51.42%)

$228,386,500 (-24.35%)

$301,899,750 (3.58%)

$291,478,250 (4.64%)

Invested Capital Average

$545,511,250 (6.71%)

$511,218,000 (-10.17%)

$569,116,000 (14.01%)

$499,189,250 (186.48%)

Shares

197,035,171 (73.27%)

113,717,785 (54.33%)

73,683,572 (153.41%)

29,077,357 (4.31%)